SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-022842
Filing Date
2021-09-29
Accepted
2021-09-29 16:15:31
Documents
17
Period of Report
2021-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20210928_8k.htm   iXBRL 8-K 36127
2 EXHIBIT 4.1 ex_287396.htm EX-4.1 85283
3 EXHIBIT 10.1 ex_287401.htm EX-10.1 444976
4 EXHIBIT 99.1 ex_287402.htm EX-99.1 27813
9 a01.jpg GRAPHIC 5400
  Complete submission text file 0001437749-21-022842.txt   867488

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA govx-20210928.xsd EX-101.SCH 4069
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20210928_def.xml EX-101.DEF 13461
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20210928_lab.xml EX-101.LAB 17682
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20210928_pre.xml EX-101.PRE 13432
10 EXTRACTED XBRL INSTANCE DOCUMENT govx20210928_8k_htm.xml XML 4403
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 211291840
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences